E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 

Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each.


Click on the deal summary to see the full details.

Valeant Pharmaceuticals International, Inc. 8.500% due 1/31/2027

Valeant Pharmaceuticals International, Inc. 9.250% due 4/1/2026

Valeant Pharmaceuticals International, Inc. 9.000% due 12/15/2025

Valeant Pharmaceuticals International, Inc. 5.500% due 11/1/2025

Valeant Pharmaceuticals International, Inc. 5.500% due 11/1/2025

Valeant Pharmaceuticals International, Inc. 6.500% due 3/15/2022

Valeant Pharmaceuticals International, Inc. 7.000% due 3/15/2024

Valeant Pharmaceuticals International, Inc. 5.500% due 3/1/2023

Valeant Pharmaceuticals International Inc. 6.500% due 7/15/2016

Valeant Pharmaceuticals International Inc. 7.250% due 7/15/2022

Valeant Pharmaceuticals International Inc. 6.750% due 10/1/2017

Valeant Pharmaceuticals International Inc. 7.000% due 10/1/2020



© 2012 Prospect News.
All content in this database is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.